logo
After hitting ‘rock bottom,' Braves can still salvage their season – if they snap out of it

After hitting ‘rock bottom,' Braves can still salvage their season – if they snap out of it

New York Times12 hours ago

The Atlanta Braves are 27-34, 11 games back in the NL East, 1 1/2 games behind rebuilding Washington and only 3 1/2 ahead of lowly Miami. After their latest misstep, a blown six-run lead in the ninth inning Thursday against Arizona, their broadcaster and Hall of Fame pitcher Tom Glavine said, 'If you were looking for rock bottom, this might be it.'
Advertisement
The tendency, in this age of overreaction, is to project the Braves as trade-deadline sellers and start listing potential landing spots for designated hitter Marcell Ozuna. But through the same date a year ago, the New York Mets were 27-35 and the Houston Astros 28-35, records nearly identical to the Braves' current mark. Both teams finished with nearly 90 wins and reached the postseason.
If the Braves fail to ignite, it will be fair to question whether they lost too much of their fabric with the free-agent departures of first baseman Freddie Freeman, shortstop Dansby Swanson and left-hander Max Fried over a four-year span. Whether president of baseball operations Alex Anthopoulos created too comfortable an environment by awarding so many players extensions. Whether Anthopoulos last offseason should have done more to address his offense and bullpen.
But more than 100 games remain. As poorly as the Braves are playing, the recoveries of the 2024 Mets and Astros are testaments to the dangers of passing judgment on a team too soon. So, for that matter, is the example of the 2021 World Series champion Braves, who at this stage of the season were 29-32.
The 162-game marathon, combined with an expanded playoff format, allows teams to recover from a bad month or even three. The Braves are unlikely to even consider selling unless they are buried at the All-Star break. Their replacement of third-base coach Matt Tuiasosopo with former manager Fredi Gonzalez on Monday was not a warning shot at manager Brian Snitker, who has led the team to seven straight postseason appearances and is in his 49th year with the organization. No, it was simply a response to two seasons of Tuiasosopo making poor decisions. A change team officials deemed necessary.
Snitker isn't blameless. The Braves aren't going to fire him after all he has achieved, but this sure looks like his last season. On Thursday alone, he could have stuck longer with right-hander Grant Holmes rather than start the bullpen carousel by lifting him after 3 1/3 innings. Still, the Braves took their six-run lead into the ninth. At some point, their disappointing performance is on the players, from center fielder Michael Harris II to second baseman Ozzie Albies to closer Raisel Iglesias.
Advertisement
By this time a year ago, the Mets already had started their turnaround. The Astros got going about two weeks later. But not every club reaches its desired destination. Another projected contender last season, the Texas Rangers, showed how some teams never recover from faulty starts, missing the playoffs one year after winning the World Series.
The Braves, if they don't snap out of it, could be this year's Rangers. Their plus-6 run differential indicates their record should be above .500, yet they are seven games under. They have played a major-league-high 25 one-run games, and are only 9-16 in those contests. Even with the deadline offering an opportunity for improvement, an opportunity Anthopoulos seized to catapult his club to a championship in 2021, the strength of the NL this season adds to the degree of difficulty.
The Braves need more from their offense, which, before their 10-run eruption Thursday, was tied with the Marlins for 22nd in runs per game. They also need to fix their bullpen, which underwent another shakeup after Thursday's shocking ninth-inning collapse — Daysbel Hernández to the injured list, Scott Blewett designated for assignment and Craig Kimbrel and Dylan Dodd up from Triple A. Yet, for all the Braves' middle-inning maneuvering, the biggest problem remains closer Raisel Iglesias, whose .956 opponents' OPS essentially means he is turning every hitter into Pete Alonso.
Not even the highly anticipated returns of right-hander Spencer Strider and right fielder Ronald Acuña Jr. altered the Braves' trajectory. Strider is trying to regain his form after missing all of 2024 recovering from Tommy John surgery and nearly a month this season with a strained right hamstring. Acuña, coming off nearly a yearlong absence due to a torn ACL in his left knee, is performing better than the Braves could have expected, batting .333 with four home runs and a 1.056 OPS. Yet the team is 3-9 since his return.
Bad breaks are part of this. The loss of right-hander Reynaldo López to shoulder inflammation after one start. The offseason knee surgery that might sideline setup man Joe Jiménez all season. The 80-game suspension to left fielder Jurickson Profar for testing positive for PEDs.
Advertisement
Well, all teams deal with injuries. The $42 million investment in Profar, based on his outlier campaign in 2024, was always going to be a gamble. And even the regressions of Harris (.590 OPS) and Albies (.658) reflect the volatility in individual performance that is part of the game. The Braves never expected catcher Drake Baldwin and outfielder Eli White to make such positive contributions, either.
Early in the offseason, Anthopoulos orchestrated a series of moves to create payroll flexibility, trading designated hitter Jorge Soler, allowing catcher Travis d'Arnaud to depart as a free agent and restructuring the contracts of López and reliever Aaron Bummer. The Braves later lost Fried, right-hander Charlie Morton and reliever A.J. Minter to free agency as well. Profar turned out to be Anthopoulos' only significant addition. And the team, under its Liberty Media ownership, wound up with a lower payroll.
Fried might win a Cy Young Award, but the Braves never were going to sign him to the $218 million contract he received from the New York Yankees, and their rotation isn't a problem. Anthopoulos non-tendered Griffin Canning, the pitcher he acquired from the Los Angeles Angels for Soler, and the Mets turned Canning into a potential All-Star. But none of the other players Anthopoulos lost is haunting him. His plan just isn't unfolding the way he envisioned.
The way the Braves are constructed, an offense that set records in 2023 should be capable of succeeding with light-hitting Nick Allen at shortstop, just as the Astros once thrived with Martín Maldonado at catcher. A better version of outfielder Jarred Kelenic, an Anthopoulos acquisition from last offseason who earned a demotion at Triple A, surely would help. But the Braves shouldn't need to rely on him, either.
Some seasons are like this. Some years it doesn't just work out. The Braves are talented enough to bounce back like they did in 2021, and like the Mets and Astros did last season. But at some point, they've got to show it. And they sure aren't showing it yet.
(Top photo of Brian Snitker: Todd Kirkland / Getty Images)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The implications of Corbin Burnes' season-ending injury go far beyond the Diamondbacks
The implications of Corbin Burnes' season-ending injury go far beyond the Diamondbacks

New York Times

time32 minutes ago

  • New York Times

The implications of Corbin Burnes' season-ending injury go far beyond the Diamondbacks

As the news on Corbin Burnes sadly demonstrates, David Stearns might have it right. Stearns, like Hall of Fame general manager Pat Gillick before him, loathes awarding long-term contracts to starting pitchers. In 11 years running the Milwaukee Brewers, who never spend big, and New York Mets, who often do, he has yet to sign a pitcher for more than he gave free-agent left-hander Sean Manaea last offseason – three years, $75 million. Advertisement Stearns was willing to make an exception during the 2023-24 offseason for Yoshinobu Yamamoto, but only because the Japanese right-hander was 25. The Mets' three rotation additions last offseason – Manaea and right-handers Clay Holmes and Griffin Canning – cost a total of $117.25 million – or nearly $100 million less than the Arizona Diamondbacks paid Burnes, the latest big-name pitcher to blow out his elbow and require Tommy John surgery. For Stearns, a second straight offseason of bargain shopping – after hitting on Manaea, Luis Severino and José Quintana in 2024 – appeared a risk. But look at the Mets now, second in the majors in rotation ERA, with another of their modest acquisitions, Paul Blackburn, shutting out the Los Angeles Dodgers for five innings Monday night in his 2025 debut. And by contrast, look at the Diamondbacks. The news Friday on Burnes severely damages the Diamondbacks' chances not just for 2025, but also 2026. The Diamondbacks, at 31-31, 6.5 games back in the NL West, entered Friday with a four-game winning streak, but qualified as something of a disappointment. If they fail to sustain their recent run, they could sell at the trade deadline rather than push forward with a $187 million payroll, the highest in the franchise's 27-year history. The implications of Burnes' surgery, though, go far beyond the Diamondbacks' immediate future. The inevitability of pitching injuries haunts the entire sport. The enjoyment of watching a Paul Skenes or Tarik Skubal dominate is tempered by a question never far from anyone's mind: Who's next? Burnes, 30, signed a six-year, $210 million free-agent contract, matching Max Scherzer for the seventh-largest guarantee awarded a pitcher. The largest and 11th largest belong to the Dodgers' Yamamoto and Blake Snell. The second, fourth and 17th largest belong to New York Yankees pitchers Gerrit Cole, lefty Max Fried and lefty Carlos Rodón.  Yamamoto missed nearly three months last season. Snell will miss at least two months this season. And those are relatively good outcomes, considering the potential for injuries that require even longer recoveries. Cole, after starting his nine-year contract with four mostly stellar seasons, is out until 2026 recovering from Tommy John surgery. Another prominent Yankees starter, reigning American League Rookie of the Year Luis Gil, has yet to pitch this season due to a lat strain. And club officials surely are concerned that Fried, in the first year of an eight-year deal, is on pace to pitch a career-high 209 innings. Advertisement The Dodgers and Yankees thrive because they spend on high-end talent, excel at pitching development and build depth to compensate for injuries. Teams without their resources cannot manage to do all three, and the Burnes injury will serve as another red flag, further discouraging mid-market teams from investing heavily in starting pitching. The next class of free-agent starters includes the Diamondbacks' Zac Gallen and Merrill Kelly, the San Diego Padres' Dylan Cease and Michael King, the Houston Astros' Framber Valdez and, if he declines a player option, the Kansas City Royals' Seth Lugo. For some of those pitchers, short-term deals with high average annual values might be a safer bet. Or maybe not. The Baltimore Orioles tried such an approach with Burnes, offering him a four-year, $180 million contract that carried an average annual value that was $10 million higher than the Diamondbacks' offer. Turns out the Orioles were fortunate Burnes said no. If he had suffered the same injury, half of the deal essentially would have gone to waste. This is an industry problem, one the sport is not close to addressing, much less fixing. Last December, Major League Baseball issued a report to the front offices of all 30 clubs, the culmination of a yearlong study on pitching injuries. Shock of shocks, the study cited the proliferation of max-effort pitching, both in velocity and movement, as the primary reason injury rates among pitchers 'skyrocketed' over the past several decades. Yet, when it comes to developing solutions, it's a wonder team executives and league officials do not blow out their own shoulders, as fiercely as they throw up their hands. Meanwhile, pitchers keep trying to throw their fastballs harder and their breaking balls sharper. Nothing will change until the incentives change, until the league implements new rules that effectively force pitchers to ease up on the throttle. Advertisement One possibility, a phased-in reduction from a maximum of 13 to 12 to perhaps even 11 pitchers, evokes fear of even more injuries. But seriously, how much worse can the situation even get? If the definition of insanity is doing the same thing over and over and expecting different results, baseball has officially gone insane. The Diamondbacks are merely the latest example of how quickly a team's best-laid intentions can go awry. A two-year, $47.5 million deal for lefty Jordan Montgomery backfired, with Montgomery ultimately requiring Tommy John surgery. A four-year, $80 million deal for lefty Eduardo Rodríguez, to this point, has been a disaster, too. And now the Diamondbacks face the potential departures of Gallen and Kelly, too. Gallen, represented by Scott Boras, has regressed to a 5.13 ERA in 13 starts, but almost certainly will seek top dollar on the open market. The Diamondbacks might stand a better chance of retaining Kelly, who is represented by Apex Baseball, but will they even want to dive back into the starting pitching market? Diamondbacks general manager Mike Hazen is not one to concede. The team perhaps has too much invested in this season to turn back. Trading Gallen and/or Kelly with Burnes and Montgomery out and Rodríguez yet to show consistency would leave the team scrambling to fill out their rotation. Then again, if the season is lost, Hazen also might feel an obligation to owner Ken Kendrick, who made a good-faith effort to build a championship roster despite playing in the same division as the spendaholic Dodgers. By parting at the deadline with their six potential free agents earning the most money – Gallen, Kelly and first baseman Josh Naylor, third baseman Eugenio Suárez, outfielder Randal Grichuk and reliever Shelby Miller – the Diamondbacks would save about $17 million. They probably wouldn't go that far, and depending upon how they are playing, might even buy and sell simultaneously. They also would need to weigh the proposed returns for Gallen and Naylor against the draft-pick compensation they would receive if the players rejected qualifying offers. But without Burnes, almost everything could end up in play. Constructing a 2026 rotation beyond Rodríguez, Brandon Pfaadt and Ryne Nelson would be a challenge. But when Hazen traded Zack Greinke at the 2019 deadline, he acquired Mike Leake to cover innings in a separate deal and also landed Gallen, then a rookie, for infielder Jazz Chisholm Jr. Hazen could back fill the same way again, and his internal rotation candidates would include converted reliever Bryce Jarvis, the reigning Pacific Coast League Pitcher of the Week, and prospects such as Cristian Mena and Yilber Díaz. Advertisement Not quite what the Diamondbacks put together this season, a powerhouse collection featuring Burnes, Gallen, Kelly, Rodríguez and Pfaadt. Kendrick and Hazen had the right idea when they signed Burnes, or at least, the right idea in theory. They were not backing down from the Dodgers. They were doing everything possible to win. That's the way the game should operate, right? Pay the best players, reap the benefits. The scourge of pitching injuries, though, is flipping the equation, to the point where Stearns' strategy might be preferable. Rather than pay top dollar for pitching, he'll simply target short-term options with upside, then rely on the Mets' pitching lab to maximize their potential. For the second straight year, it's working. And even if recent acquisitions like Holmes and Canning fail to sustain success, Stearns faces only so much downside. When it comes to signing starting pitchers, he will go only so far. And never as far as the Diamondbacks did for Corbin Burnes. (Top photo of Burnes and Diamondbacks assistant athletic trainer Max Esposito:)

Yankees' Weaver has PRP injection in hamstring; Stanton could start minor league rehab next week
Yankees' Weaver has PRP injection in hamstring; Stanton could start minor league rehab next week

Washington Post

time41 minutes ago

  • Washington Post

Yankees' Weaver has PRP injection in hamstring; Stanton could start minor league rehab next week

NEW YORK — Yankees closer Luke Weaver had a platelet rich plasma injection in his injured left hamstring, and designated hitter Giancarlo Stanton is on track to start a minor league rehabilitation assignment next week. Weaver was hurt Sunday while warming up at the Los Angeles Dodger s. He is projected to be sidelined for four to six weeks. The PRP is designed to speed healing.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store